Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Ligand Pharmaceuticals Incorporated”

124 pharma patents match "Ligand Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 124
Index total 30,257
Page 4 / 6

Quick answer

This filtered view shows 124 pharmaceutical patents matching "Ligand Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

124 results for “Ligand Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 6794373

    Contraceptive methods using benzimidazolones

    Ligand Pharmaceuticals Incorporated · Granted Sep 21, 2004 · Expires Sep 16, 2024

    expired

  2. US 6759408

    Combination regimens using progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Jul 6, 2004 · Expires Jul 1, 2024

    expired

  3. US 6713478

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Mar 30, 2004 · Expires Mar 25, 2024

    expired

  4. US 6696459

    Steroid receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired

  5. US 6693103

    1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired

  6. US 6670387

    Thrombopoietin mimetics

    Ligand Pharmaceuticals Incorporated · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  7. US 6667313

    8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  8. US 6610696

    Modulators of peroxisome proliferator activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Aug 26, 2003 · Expires Aug 21, 2023

    expired

  9. US 6608068

    Indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Aug 19, 2003 · Expires Aug 14, 2023

    expired

  10. US 6593493

    RXR modulators with improved pharmacologic profile

    Ligand Pharmaceuticals Incorporated · Granted Jul 15, 2003 · Expires Jul 10, 2023

    expired

  11. US 6583145

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated · Granted Jun 24, 2003 · Expires Jun 19, 2023

    expired

  12. US 6576676

    Means for the modulation of processes mediated by retinold receptors and compounds useful therefor

    Ligand Pharmaceuticals Incorporated · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired

  13. US 6566372

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted May 20, 2003 · Expires May 15, 2023

    expired

  14. US 6566358

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted May 20, 2003 · Expires May 15, 2023

    expired

  15. US 6544970

    Cyclic regimens utilizing indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Apr 8, 2003 · Expires Apr 3, 2023

    expired

  16. US 6545049

    Dimer-selective RXR modulators and methods for their use

    Ligand Pharmaceuticals Incorporated · Granted Apr 8, 2003 · Expires Apr 3, 2023

    expired

  17. US 6521633

    Treating NIDDM with RXR agonists

    Ligand Pharmaceuticals Incorporated · Granted Feb 18, 2003 · Expires Feb 13, 2023

    expired

  18. US 6521657

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated · Granted Feb 18, 2003 · Expires Feb 13, 2023

    expired

  19. US 6509334

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Jan 21, 2003 · Expires Jan 16, 2023

    expired

  20. US 6506766

    Glucocortiocoid-selective antinflammatory agents

    Ligand Pharmaceuticals Incorporated · Granted Jan 14, 2003 · Expires Jan 9, 2023

    expired

  21. US 6503939

    Combination regimens using 3,3-substituted indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Jan 7, 2003 · Expires Jan 2, 2023

    expired

  22. US 6498154

    Cyclic regimens using quinazolinone and benzoxazine derivatives

    Ligand Pharmaceuticals Incorporated · Granted Dec 24, 2002 · Expires Dec 19, 2022

    expired

  23. US 6462032

    Cyclic regimens utilizing indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Oct 8, 2002 · Expires Oct 3, 2022

    expired

  24. US 6462038

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Oct 8, 2002 · Expires Oct 3, 2022

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.